The impact of tumor grade on survival end points and patterns of recurrence of 949 patients with early-stage endometrioid carcinoma : A single institution study

International Journal of Gynecological Cancer

Volumn 24, Issue 1, 2014, Pages 97-101

  Gayar, Omar H ^a   Patel, Suketu ^a   Schultz, Daniel ^a   Mahan, Meredith ^a   Rasool, Nabila ^a   Elshaikh, Mohamed A ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Endometrial carcinoma; Grade; Prognosis; Recurrence; Uterine cancer

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ASCITES FLUID CYTOLOGY; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH NODE DISSECTION; LYMPH VESSEL; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SALPINGOOOPHORECTOMY; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; ENDOMETRIAL NEOPLASMS; FEMALE; GENITALIA, FEMALE; HUMANS; MICHIGAN; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 84891862952     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000018     Document Type: Conference Paper

References (22)

1. American Cancer Society. Cancer Facts & Figures 2012. Atlanta, Ga: American Cancer Society; 2012.
2. Creasman WT, Morrow PC, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60:2035-2041.
3. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991;40:55-65.
4. Grigsby PW, Perez CA, Kuten A, et al. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system. Int J Radiat Oncol Biol Phys. 1992;22:905-911.
5. Fujimoto T, Nanjyo H, Fukuda J, et al. Endometrioid uterine cancer: histopathological risk factors of local and distant recurrence. Gynecol Oncol. 2009;112:342-347.
6. Long KC, Zhou Q, Hensley ML, et al.Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer. Gynecol Oncol. 2012;125:99-102.
7. Rasool N, Fader AN, Seamon L, et al. Stage I, grade 3 endometrioid adenocarcinoma of the endometrium: an analysis of clinical outcomes and patterns of recurrence. Gynecol Oncol. 2010;116:10-14.
8. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Lancet. 2000;355:1404-1411.
9. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
10. Esselen KM, Boruta DM, del Carmen M, et al. Defining prognostic variables in recurrent endometrioid endometrial cancer: a 15-year single-institution review. Int J Gynecol Cancer. 2011;21:1078-1083.
11. Greven KM, Randall M, Fanning J, et al.Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 1990;19:529-534.
12. Zaki MA, Robbins JR, Fatteh S, et al. Histological grade predicts for recurrence in patients with uterine endometrioid carcinoma without myometrial involvement. Anticancer Res. 2012;32:4061-4065.
13. Mariani A, Dowdy SC, Keeney GL, et al.Predictors of vaginal relapse in stage I endometrial cancer. Gynecol Oncol. 2005;97:820-827.
14. Creasman WT, Odicino F, Maisonneuve P, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95:S105-S143.
15. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, et al. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol. 2004;22:1234-1241.
16. Konski A, Domenico D, Tyrkus M, et al. Prognostic characteristics of surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys. 1996;35:935-940.
17. Alektiar KM, Venkatraman E, Chi DS, et al. Intracavitary brachytherapy alone for intermediate-risk endometrial cancer. Int J Radiat Oncology Biol Phys. 2005;62:111-117.
18. Robbins JR, Yechieli R, Laser B, et al.Is time to recurrence after hysterectomy predictive of survival in patients with early stage endometrial carcinoma?Gynecol Oncol. 2012;127:38-42.
19. American Joint Committee on Cancer (AJCC). Cancer Staging Manual. 7th ed. Springer New York; 2010:103.
20. Corn BW, Lanciano RM, D?agostino R, et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol. 1997;66:411-416.
21. Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer. 2006;95:266-271.
22. Hogberg T, Signorelli M, de Oliveira CF, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancerVresults from two randomised studies. Eur J Cancer. 2010;46:2422-2431.